Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Persistent DNMT3A Mutations Predicting Relapse After Acute Myeloid Leukemia Remission: A Systematic Review of Molecular Persistence and Circulating DNA Dynamics

AML - 454

Persistent DNMT3A Mutations Predicting Relapse After Acute Myeloid Leukemia Remission: A Systematic Review of Molecular Persistence and Circulating DNA Dynamics

Sahar Amjad

Poster Presenter: Sahar Amjad

Thumbnail for Persistent Excess Risk of Second Primary Malignancies in Follicular Lymphoma Survivors: Site-Specific and Latency-Based Findings from SEER, 2000-2022.

ABCL - 1584

Persistent Excess Risk of Second Primary Malignancies in Follicular Lymphoma Survivors: Site-Specific and Latency-Based Findings from SEER, 2000-2022.

Muhammad Sarfraz Khan

Poster Presenter: Muhammad Sarfraz Khan

Thumbnail for Persistent Gender, Racial, and Urban-Rural Disparities in Mantle Cell Lymphoma Mortality in the United States, 1999-2024: Evidence of Stalled Progress in the Targeted Therapy Era

MCL - 167

Persistent Gender, Racial, and Urban-Rural Disparities in Mantle Cell Lymphoma Mortality in the United States, 1999-2024: Evidence of Stalled Progress in the Targeted Therapy Era

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for Persistent Inequities in Multiple Myeloma Mortality Despite Therapeutic Advances in the United States

MM - 1145

Persistent Inequities in Multiple Myeloma Mortality Despite Therapeutic Advances in the United States

Baqir Jafry

Poster Presenter: Baqir Jafry

Thumbnail for Persistent Infectious and Thrombotic Co-Mortality in Myeloproliferative Neoplasm-Associated Deaths: A National Multiple-Cause-of-Death Analysis (2003-2024)

MPN - 696

Persistent Infectious and Thrombotic Co-Mortality in Myeloproliferative Neoplasm-Associated Deaths: A National Multiple-Cause-of-Death Analysis (2003-2024)

Kristina Agustino

Poster Presenter: Kristina Agustino

Thumbnail for Persistent Site-Specific Excess Risk of Second Primary Malignancies Among Diffuse Large B-Cell Lymphoma Survivors: A SEER-Based Analysis from 2000-2022

ABCL - 1574

Persistent Site-Specific Excess Risk of Second Primary Malignancies Among Diffuse Large B-Cell Lymphoma Survivors: A SEER-Based Analysis from 2000-2022

Imran Khan

Poster Presenter: Imran Khan

Thumbnail for PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

HL - 1412

PET-GUIDED NIVOLUMAB-BASED FIRST-LINE STRATEGY IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM CLINICAL RESULTS

Hunan Julhakyan

Poster Presenter: Hunan Julhakyan

Thumbnail for Phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), and clinical activity of the antibody-drug conjugate (ADC) ARC-02 as monotherapy and in combination with rituximab in adults with B-cell non-Hodgkins lymphoma (NHL)

ABCL - 1058

Phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), and clinical activity of the antibody-drug conjugate (ADC) ARC-02 as monotherapy and in combination with rituximab in adults with B-cell non-Hodgkins lymphoma (NHL)

Sinya Okamura

Poster Presenter: Sinya Okamura

Thumbnail for Phase 3 Randomized Trial of Anselamimab Demonstrates Improvement in All-Cause Mortality in κ Light-Chain Amyloidosis

MM - 218

Phase 3 Randomized Trial of Anselamimab Demonstrates Improvement in All-Cause Mortality in κ Light-Chain Amyloidosis

Giada Bianchi

Poster Presenter: Giada Bianchi

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.